Elevated plasma levels of specific antiplatelet glycoprotein autoantibodies in patients with primary Sjögren syndrome with thrombocytopenia
- PMID: 37999855
- DOI: 10.1007/s10067-023-06818-y
Elevated plasma levels of specific antiplatelet glycoprotein autoantibodies in patients with primary Sjögren syndrome with thrombocytopenia
Abstract
Introduction: Thrombocytopenia is one of the primary Sjögren's syndrome (pSS) hematological manifestations. The objective of this study was to evaluate the possible roles of antiplatelet glycoprotein autoantibodies in the pathogenesis of thrombocytopenia in primary Sjögren's syndrome (pSS).
Methods: The level of plasma anti-glycoprotein Ib, IIIa and IIb/IIIa autoantibodies in 36 pSS patients without thrombocytopenia and 35 pSS patients with thrombocytopenia, 36 Idiopathic thrombocytopenic purpura (ITP) patients and 39 normal control were measured with enzyme-linked immunosorbent assay (ELISA).
Results: The level of anti-GPIb, GPIIIa, GPIIb/IIIa autoantibodies (A490) in the pSS with thrombocytopenia was significantly higher than that of pSS without thrombocytopenia (0.813 ± 0.161 vs 0.688 ± 0.133; 0.917 ± 0.094 vs 0.802 ± 0.070; 0.911 ± 0.125 vs 0.782 ± 0.109). Incidences of the anti-GPIb, GPIIIa, GPIIb/IIIa autoantibodies in the pSS with thrombocytopenia was significantly higher than that of pSS without thrombocytopenia (25.7% vs 0%; 65.7% vs 11.1%; 31.4% vs 0%). In patients with pSS, there was a lower platelet count in anti-GPIb, GPIIIa, GPIIb/IIIa autoantibodies positive patients ((25.67 ± 5.5) × 10^9/L vs (116.8 ± 84.52) × 10^9/L; 29.04 ± 11.33 × 10^9/L vs (152.0 ± 75.47) × 10^9/L; (31.55 ± 14.0) × 10^9/L vs (118.8 ± 85.24) × 10^9/L).
Conclusion: Elevated plasma levels of anti-platelet glycoprotein autoantibodies may play a role in the pathogenesis of thrombocytopenia in pSS. Key Points • The level of anti-GPIb, GPIIIa, GPIIb/IIIa autoantibodies (A490) in the pSS with thrombocytopenia was increased. • Incidences of the anti-GPIb, GPIIIa, GPIIb/IIIa autoantibodies in the pSS with thrombocytopenia was increased. • In patients with pSS, there was a lower platelet count in anti-GPIb, GPIIIa, GPIIb/IIIa autoantibodies positive patients.
Keywords: Autoantibodies; Idiopathic; Primary; Sjögren’s Syndrome; Thrombocytopenia; Thrombocytopenic.
© 2023. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).
Similar articles
-
Platelet-associated antibody to glycoprotein IIb/IIIa from chronic immune thrombocytopenic purpura patients often binds to divalent cation-dependent antigens.Blood. 1993 Mar 1;81(5):1284-9. Blood. 1993. PMID: 7680243
-
Different specificities of platelet-associated and plasma autoantibodies to platelet GPIIb-IIIa in patients with chronic immune thrombocytopenic purpura.Blood. 1992 Mar 15;79(6):1441-6. Blood. 1992. PMID: 1547343
-
Elevated Plasma P-Selectin Autoantibodies in Primary Sjögren Syndrome Patients with Thrombocytopenia.Med Sci Monit. 2015 Nov 28;21:3690-5. doi: 10.12659/msm.895144. Med Sci Monit. 2015. PMID: 26613867 Free PMC article.
-
[Detection of anti-GPIIb-IIIa autoantibodies and its clinical significance in autoimmune thrombocytopenic purpura].Rinsho Byori. 1997 Oct;45(10):934-41. Rinsho Byori. 1997. PMID: 9369070 Review. Japanese.
-
Megakaryocytes and platelets in immune thrombocytopenic purpura.Baillieres Clin Haematol. 1997 Feb;10(1):89-107. doi: 10.1016/s0950-3536(97)80052-2. Baillieres Clin Haematol. 1997. PMID: 9154317 Review.
References
MeSH terms
Substances
Grants and funding
- 82170217/National Nature Science Foundation of China
- 20JCZDJC00410/Key Project of Tianjin Natural Science Foundation
- 2021-I2M-1-073/CAMS Innovation Fund for Medical Sciences
- 2022-I2M-C&T-B-091/CAMS Innovation Fund for Medical Sciences
- 2022 TSHRM08003/Clinical research project of Tianjin Society of Hematology and Regenerative Medicine
LinkOut - more resources
Full Text Sources
Medical